| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Laboratories of
*
Immunology and
Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
B10.Q mice are normally susceptible to the induction of
collagen-induced arthritis. We noted that one subline of B10.Q mice,
B10.Q/J, was completely resistant to disease induction when immunized
with collagen in CFA. B10.Q/J mice have a global defect in the
generation of Th1 responses, and Ag-specific T cells derived from this
strain failed to produce IFN-
. Because T cells from these mice could
produce normal amounts of IFN- when activated by
IL-12/IL-18-independent stimuli, the defect appeared to be a failure to
respond to IL-12. This defect extended to NK cells, which also failed
to produce IFN- when stimulated by IL-12. The capacity of NK cells,
but not activated T cells, to produce IFN- in response to IL-12
could be partially restored by IL-18. The expression of the IL-12R
1- and 2-chains on T cells and NK cells from B10.Q/J mice was
normal. However, activated T cells from B10.Q/J mice did not signal
normally through the IL-12R and manifested a defect in their capacity
to phosphorylate Stat4. This defect was partial in that it could be
overcome by increasing both the concentration of IL-12 and the
incubation times in the Stat4 phosphorylation assays. Because Stat4
function is apparently intact in B10.Q/J mice, the defect in IL-12
signaling can be localized between the IL-12R complex and Stat4. This
subtle abnormality in IL-12 responsiveness results in a profound defect
in the generation of Th1 cells and the development of autoimmune
disease.
This article has been cited by other articles:
|
|
 |
|
  K. M. Spach, R. Noubade, B. McElvany, W. F. Hickey, E. P. Blankenhorn, and C. Teuscher A Single Nucleotide Polymorphism in Tyk2 Controls Susceptibility to Experimental Allergic Encephalomyelitis J. Immunol., June 15, 2009; 182(12): 7776 - 7783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Shaw, G. J. Freeman, M. F. Scott, B. A. Fox, D. J. Bzik, Y. Belkaid, and G. S. Yap Tyk2 Negatively Regulates Adaptive Th1 Immunity by Mediating IL-10 Signaling and Promoting IFN-{gamma}-Dependent IL-10 Reactivation. J. Immunol., June 15, 2006; 176(12): 7263 - 7271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J J O'Shea Targeting the Jak/STAT pathway for immunosuppression Ann Rheum Dis, November 1, 2004; 63(suppl_2): ii67 - ii71. [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Shaw, V. Boyartchuk, S. Wong, M. Karaghiosoff, J. Ragimbeau, S. Pellegrini, M. Muller, W. F. Dietrich, and G. S. Yap A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity PNAS, September 30, 2003; 100(20): 11594 - 11599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kuroda, T. Kito, and U. Yamashita Reduced Expression of STAT4 and IFN-{gamma} in Macrophages from BALB/c Mice J. Immunol., June 1, 2002; 168(11): 5477 - 5482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Yap, R. Ortmann, E. Shevach, and A. Sher A Heritable Defect in IL-12 Signaling in B10.Q/J Mice. II. Effect on Acute Resistance to Toxoplasma gondii and Rescue by IL-18 Treatment J. Immunol., May 1, 2001; 166(9): 5720 - 5725. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
